Interferon-Free Strategies without a Nucleoside/Nucleotide Analogue

The publisher regrets two errors in the above article in Seminars in Liver Disease, Volume 34, Number 1, 2014, 52 and 54 (DOI: 10.1055/s-0034-1371010). In Table 2, on page 52 under the heading “Sponsor,” “Boehringer-Ingelheim” should actually read “Boehringer-Ingelheim/Presidio.” Additionally, on page 54 under the heading Summary and Perspectives, in the tenth line down the phrase “the current HCV treatment landscape” should be deleted, as it appears twice.